A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT00077350 · COMPLETED
Trial details
- NCT number
- NCT00077350
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2005-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.